Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2006-06-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clopidogrel Resistance and the Possibility of Its Affection
NCT00839345
Influence of Varenicline on the Antiplatelet Action of Clopidogrel
NCT01308671
POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
NCT05926271
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
NCT06198673
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
NCT00404781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Unstable
Patient with acute myocardial infarction plus severe hemodynamical instability. It means, on mechanical ventilation and catecholamine support
No interventions assigned to this group
Stable
Patients with myocardial infarction hemodynamically completely (Killip I)stable.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mechanical ventilation
* the need for catecholamine support.
* acute myocardial infarction
Exclusion Criteria
* clopidogrel administration during transport by ambulance
* known intolerance to clopidogrel
* history of thrombocytopenia (\<150,000 platelets/ml)
* pre-existing liver disease
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charles University Prague
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pavel Osmancik, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Charles University Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske Vinohrady
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLO-OSM-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.